Altium Capital Management

https://lnkd.in/d5CtaCKu "A group of premier investors participated in the PIPE financing, including RTW Investments LP, Surveyor Capital (a Citadel company), Chardan Healthcare Investments, Acorn Bioventures, Innogest Capital and Longview Ventures (an affiliate of Broadview Ventures). Other top-tier investors participating in the business combination include 683 Capital, Affinity Asset Advisors, Altium Capital, Ikarian Capital, Sio Capital Management and South Ocean Capital Management"

https://www.streetinsider.com//Cellect+Biote/18172996.html

"The financing from leading healthcare investors included Farallon Capital Management, Polaris Partners, HBM Healthcare Investments, Altium Capital Management.."

Altium Capital and Sio Capital recently formed Medicus Sciences Acquisition Corp., a $92 million SPAC publicly traded on the Nasdaq under the symbol, MSACU, for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. While Medicus may acquire a company in any industry, its focus is on the healthcare industry, particularly the medical technology sector. In addition, Altium and Sio have entered into forward purchase agreements to invest up to $16 million in connection with an initial business combination with Medicus. https://t.co/imZvNH3oxr?amp=1

A single shot of a coronavirus vaccine developed by Johnson & Johnson protected volunteers enrolled in a sprawling, multi-country study from developing COVID-19 #healthnews #biotech #vaccinecovid19

Merck & Co. will stop developing two experimental coronavirus vaccines after both produced disappointing results in early-stage testing. #healthnews #biotech #Covid19

After a record year for biotech IPOs in 2020, forecasts were bullish on another strong year showing for public offerings and 2021 hasn’t disappointed so far. #biotech #healthnews https://endpts.com/the-ipo-flood-keeps-rising-with-4-more-/

US pays another $2B to buy more doses of Pfizer, BioNTech coronavirus vaccine

The US looks set to go from zero to two Covid-19 vaccines in a week. #healthnews #Covid19 https://endpts.com/fda-docs-give-moderna-green-light-while/

Remix Therapeutics debuts with $81M to 'reprogram' disease-causing RNA https://www.fiercebiotech.com//remix-therapeutics-debuts-8

Merck opts in for Dragonfly's TriNKET cancer immunotherapy program

Anti-aging biotech Elevian raises $15M as it looks to the clinic https://www.fiercebiotech.com//anti-ageing-biotech-elevian